| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |